Drug: NAPROSYN Injury: Atrial fibrillation Quarter: 2016Q3
Total Records: 7 Number of Pages: 1
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 126108401 | NAPROSYN | Atrial fibrillation | AMGEN | 0.00 | F | 0 | 20160801 | CA |
| 126163942 | NAPROSYN | Atrial fibrillation | PFIZER | 0.00 | F | 0 | 20160808 | CA |
| 126590571 | NAPROSYN | Atrial fibrillation | INTERCHEM | 0.00 | F | 0 | 20160817 | CA |
| 127869481 | NAPROSYN | Atrial fibrillation | ABBVIE | 69.00 YR | M | 90 KG | 20160927 | US |
| 127968651 | NAPROSYN | Atrial fibrillation | BAYER | 69.00 YR | M | 90 KG | 20160929 | US |
| 127994741 | NAPROSYN | Atrial fibrillation | MERCK | 69.00 YR | M | 90 KG | 20160930 | US |
| 923078055 | NAPROSYN | Atrial fibrillation | ROCHE | 75.88 YR | F | 98 KG | 20160913 | CA |
Total Records: 7 Number of Pages: 1